Drug details

Omtryg (omega-3-acid ethyl esters a capsules)

type of Nutritionals, Other, Lipid-Lowering Agents, Other

Omtryg (omega-3-acid ethyl esters A) is a lipid-regulating agent used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.

This drug may have the following side effects:

• itching
• 
  belching
• changes in the sense of taste
• indigestio,
• constipation
• upset stomach
• vomiting
• rash.

The following drugs are related to Omtryg, either as a replacement or used together:

• Caduet (amlodipine besylate, atorvastatin calcium)
• Lipitor (atorvastatin calcium)
• Baycol (cerivastatin (removed from market 8/2001))
• Colestid (colestipol)
• Crestor (rosuvastatin calcium)
• Epanova (omega-3-carboxylic acids soft-gelatin capsules)
• Vytorin (ezetimibe and simvastatin)
• Zetia (ezetimibe tablets)
• Mevacor (lovastatin)
• Roszet (rosuvastatin and ezetimibe tablets)
• Zocor (simvastatin)